Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Robert C. Kurtz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0002-6493-3136; OpenAlex author ID A5089633724. Sources: OpenAlex.

Their work

Papers
45 (first author 2, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
119
Papers, trials and grants by year

2011: 5 papers · 2012: 6 papers · 2013: 5 papers · 2014: 4 papers · 2015: 2 papers · 2016: 5 papers · 2017: 2 papers · 2018: 1 paper · 2019: 3 papers · 2020: 4 papers · 2021: 4 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 45

  1. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  2. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  3. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  4. Association Between Polycystic Ovary Syndrome and Risk of Pancreatic Cancer. Co-author DOI 10.1001/jamaoncol.2022.4540↗
  5. The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response. Co-author DOI 10.1002/humu.24133↗
  6. A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population. Co-author DOI 10.1007/s00439-020-02205-8↗
  7. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  8. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  9. Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Co-author DOI 10.1002/gepi.22348↗
  10. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  11. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  12. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  13. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  14. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Co-author DOI 10.1158/1055-9965.epi-18-1235↗
  15. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2. Last author DOI 10.1158/1940-6207.capr-18-0272↗
  16. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis. Co-author DOI 10.1097/mpa.0000000000000989↗
  17. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study. Last author DOI 10.1007/s10552-017-0933-8↗
  18. Epidemiology of pancreatic adenocarcinoma. Last author DOI 10.21037/cco.2017.06.32↗
  19. Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression. Co-author DOI 10.1093/hmg/ddw300↗
  20. Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000000590↗
  21. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC… Co-author DOI 10.1097/mpa.0000000000000635↗
  22. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-15-0402↗
  23. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  24. Identification of germline genetic mutations in patients with pancreatic cancer. Co-author DOI 10.1002/cncr.29664↗
  25. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  26. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  27. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdu276↗
  28. Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Co-author DOI 10.1158/1055-9965.epi-13-1359↗
  29. Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk. Co-author DOI 10.3389/fgene.2014.00029↗
  30. Epidemiology of pancreatic cancer and the role of family history. First author DOI 10.1002/jso.23149↗
  31. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  32. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/aje/kwt052↗
  33. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdt336↗
  34. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  35. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Co-author DOI 10.1002/cncr.26191↗
  36. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Co-author DOI 10.1093/annonc/mdr541↗
  37. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mds140↗
  38. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Co-author DOI 10.1093/carcin/bgs151↗
  39. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Co-author DOI 10.1158/1078-0432.ccr-11-2856↗
  40. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-012-2301-y↗
  41. Feasibility and yield of screening in relatives from familial pancreatic cancer families. Last author DOI 10.1038/ajg.2011.65↗
  42. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdq613↗
  43. Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? Co-author DOI 10.1093/annonc/mdr305↗
  44. An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. Co-author DOI 10.1634/theoncologist.2011-0185↗
  45. Pancreatic tumor: when is it not pancreatic adenocarcinoma? First author PMID 22347826↗

Closest collaborators

The 25 strongest of 119 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sara H. Olson · 24 shared papers, 2011–2021 · strength 1.23
  2. Harvey A. Risch · 9 shared papers, 2011–2021 · strength 0.44
  3. Paige M. Bracci · 11 shared papers, 2011–2020 · strength 0.39
  4. Steve Gallinger · 11 shared papers, 2011–2020 · strength 0.39
  5. Amethyst Saldia · 5 shared papers, 2015–2019 · strength 0.35
  6. Eric J. Duell · 9 shared papers, 2011–2020 · strength 0.29
  7. Alison P. Klein · 4 shared papers, 2016–2021 · strength 0.28
  8. Carlo La Vecchia · 9 shared papers, 2011–2018 · strength 0.28
  9. Gloria M. Petersen · 9 shared papers, 2011–2019 · strength 0.27
  10. Donghui Li · 4 shared papers, 2016–2020 · strength 0.27
  11. Rayjean J. Hung · 3 shared papers, 2018–2020 · strength 0.23
  12. Herbert Yu · 7 shared papers, 2011–2019 · strength 0.21
  13. Rachel Ε. Neale · 4 shared papers, 2013–2020 · strength 0.21
  14. H. Bas Bueno-de-Mesquita · 8 shared papers, 2011–2016 · strength 0.20
  15. Mengmeng Du · 1 shared paper, 2022 · strength 0.19
  16. Noah Charles Peeri · 1 shared paper, 2022 · strength 0.19
  17. Cristina Bosetti · 6 shared papers, 2011–2018 · strength 0.18
  18. Eileen Mary O'Reilly · 4 shared papers, 2011–2017 · strength 0.18
  19. Ghislaine Scélo · 3 shared papers, 2014–2020 · strength 0.18
  20. Laufey Thora Amundadottir · 2 shared papers, 2016–2021 · strength 0.18
  21. Zsofia Kinga Stadler · 4 shared papers, 2011–2019 · strength 0.18
  22. Erin E. Salo‐Mullen · 4 shared papers, 2011–2019 · strength 0.18
  23. Debra T. Silverman · 7 shared papers, 2011–2014 · strength 0.17
  24. Rachael Z. Stolzenberg‐Solomon · 3 shared papers, 2014–2018 · strength 0.16
  25. Elizabeth T. H. Fontham · 7 shared papers, 2011–2014 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.